Taurine in Energy Drinks Linked to Cancer
Analysis based on 6 articles · First reported May 15, 2025 · Last updated May 21, 2025
The study linking Taurine to increased blood cancer risk could negatively impact the sales and stock prices of companies like Red Bull GmbH and Celsius Holdings, which use Taurine in their products. Conversely, it may spur investment in pharmaceutical companies researching new leukemia treatments by blocking Taurine.
A new study by the University of Rochester's Wilmot Cancer Institute, published in Nature (journal), suggests that Taurine, a common ingredient in energy drinks like Red Bull GmbH and Celsius Holdings, may increase the risk of blood cancers, particularly leukemia. Researchers found that leukemia cells absorb Taurine to fuel their growth through glycolysis. While Taurine is naturally produced in the body and found in foods, excessive intake through supplements and energy drinks could exacerbate leukemia. The study, conducted on mice with the SLC6A6 gene and human leukemia cells, highlights the need to carefully consider the risks and benefits of supplemental Taurine. Researchers are optimistic that blocking Taurine in leukemia cells could lead to new treatment options and are investigating its role in other cancers like colorectal cancer. The American Cancer Society and Australia provide statistics on the prevalence of blood cancers, underscoring the public health significance of these findings.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard